Genetically engineered mouse models of human B-cell precursor leukemias.

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• B-cell precursor acute lymphoblastic leukemia (pB-ALL) is a common childhood cancer with diverse clinical and pathological presentations.
• Understanding the underlying molecular alterations is key to improving patient outcomes.
• Multidisciplinary efforts are essential for advancing pB-ALL research and treatment.

Purpose of the Study:

• To review genetically engineered mouse models (GEMMs) of human pB-ALL developed over the past 20 years.
• To establish guidelines for creating an "ideal" animal model for pB-ALL research.
• To promote standardized criteria for drug testing and environmental risk factor analysis in pB-ALL.

Main Methods:

• Review of historically, technically, and biologically relevant GEMMs of human pB-ALL.
• Analysis of the utility of GEMMs in understanding pB-ALL origin, evolution, and therapeutic development.
• Formulation of guidelines for developing standardized pB-ALL animal models.

Main Results:

• GEMMs are powerful tools for studying pB-ALL biology and developing novel therapies.
• Existing GEMMs offer valuable insights into the diverse nature of pB-ALL.
• There is a need for standardized models to facilitate comparative research and drug development.

Conclusions:

• Standardized, shared GEMMs are essential for advancing pB-ALL research.
• Ideal GEMMs will unify criteria for drug testing, environmental risk assessment, and mutation studies.
• Development of optimal animal models will accelerate progress towards curing pB-ALL.